BChE-IN-14
BChE-IN-14 (compound 19c) is a selective butyrylcholinesterase (BChE) inhibitor with IC50s of 0.23 and 0.011 μM for eqBChE and hBChE, respectively. BChE-IN-14 shows good blood brain barrier permeation and primary cell safety. BChE-IN-14 is able to restore cognitive impairment in vivo, it can be used for the research of Alzheimer’s disease.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2700896-78-0
- Formel: C24H29N
- Molecular Weight:331.49
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
IC50: 0.23 μM (eqBChE), 0.011 μM (hBChE)[1]
BChE-IN-14 (0.0001-100 μM) inhibits eqBChE from house serum and hBChE with IC50s of 0.23 and 0.011 μM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR mice with oligomerized Aβ1-42 peptide injection[1]
-
Dosage:15 mg/kg
-
Administration:Oral gavage; 15 mg/kg for Aβ1-42 injection days 3-8
-
Result:Improved memory and cognitive function in vivo and showed a shorter latency than donepezil.
Chemical Information
-
CAS. Nr. 2700896-78-0
-
Molecular Weight 331.49
-
Formel C24H29N
-
SMILES
CCCCN(CC1=CC=C2C=CC=CC2=C1)CCCC3=CC=CC=C3
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)